ATTACQ LIMITED - Dealing in securities by a director and prescribed officers of the company

Dealing in securities by a director and prescribed officers of the company

ATTACQ LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 1997/000543/06)
JSE share code: ATT ISIN: ZAE000177218
(Approved as a REIT by the JSE)
("Attacq" or "the company")


DEALING IN SECURITIES BY A DIRECTOR AND PRESCRIBED OFFICERS OF THE COMPANY


Shareholders are advised of the following information relating to the award of conditional performance shares
("CPSs") and acceptance thereof by a director and prescribed officers under the Attacq Limited Long-Term
Incentive Plan ("LTIP") which are subject to various performance conditions set and agreed by the
Remuneration and Nominations Committee, in line with the strategic objectives of the company, together with
the award of retention shares and acceptance thereof by a director and prescribed officers under the LTIP, which
awards are not subject to performance conditions. These awards will vest in three tranches on a 60%, 20%, 20%
basis in 3, 4 and 5 years' time respectively.

Name of director:                                  Raj Nana
Transaction date:                                  14 October 2021
Class of security:                                 Options over ordinary shares
Number of securities:                              67 707
Price per security                                 R6.54
Total value:                                       R442 803.78
Nature of transaction:                             Award of retention shares in terms of the LTIP
Nature and extent of director's interest           Direct beneficial
Clearance to deal obtained:                        Yes

Name of director:                                  Raj Nana
Transaction date:                                  14 October 2021
Class of security:                                 Options over ordinary shares
Number of securities:                              270 827
Price per security                                 R6.54
Total value:                                       R1 771 208.58
Nature of transaction:                             Allocation of CPSs in terms of the LTIP
Nature and extent of director's interest           Direct beneficial
Clearance to deal obtained:                        Yes

Name of prescribed officer:                        Giles Pendleton
Transaction date:                                  14 October 2021
Class of security:                                 Options over ordinary shares
Number of securities:                              50 358
Price per security                                 R6.54
Total value:                                       R329 341.32
Nature of transaction:                             Award of retention shares in terms of the LTIP
Nature and extent of director's interest           Direct beneficial
Clearance to deal obtained:                        Yes

Name of prescribed officer:                        Giles Pendleton
Transaction date:                                  14 October 2021
Class of security:                                 Options over ordinary shares
Number of securities:                              201 431
Price per security                                 R6.54
Total value:                                       R1 317 358.74
Nature of transaction:                             Allocation of CPSs in terms of the LTIP
Nature and extent of director's interest           Direct beneficial
Clearance to deal obtained:                        Yes

Name of prescribed officer:                        Peter de Villiers
Transaction date:                                  14 October 2021
Class of security:                                 Options over ordinary shares
Number of securities:                              30 696
Price per security                                 R6.54
Total value:                                       R200 751.84
Nature of transaction:                             Award of retention shares in terms of the LTIP
Nature and extent of director's interest           Direct beneficial
Clearance to deal obtained:                        Yes

Name of prescribed officer:                        Peter de Villiers
Transaction date:                                  14 October 2021
Class of security:                                 Options over ordinary shares
Number of securities:                              122 786
Price per security                                 R6.54
Total value:                                       R803 020.44
Nature of transaction:                             Allocation of CPSs in terms of the LTIP
Nature and extent of director's interest           Direct beneficial
Clearance to deal obtained:                        Yes

Name of prescribed officer:                        Debbie Theron
Transaction date:                                  14 October 2021
Class of security:                                 Options over ordinary shares
Number of securities:                              28 318
Price per security                                 R6.54
Total value:                                       R185 199.72
Nature of transaction:                             Award of retention shares in terms of the LTIP
Nature and extent of director’s interest           Direct beneficial
Clearance to deal obtained:                        Yes

Name of prescribed officer:                        Debbie Theron
Transaction date:                                  14 October 2021
Class of security:                                 Options over ordinary shares
Number of securities:                              113 274
Price per security                                 R6.54
Total value:                                       R740 811.96
Nature of transaction:                             Allocation of CPSs in terms of the LTIP
Nature and extent of director’s interest           Direct beneficial
Clearance to deal obtained:                        Yes

18 October 2021

Sponsor
Java Capital

Date: 18-10-2021 04:05:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.